Calciphylaxis of the breast: a rare metabolic complication of kidney disease
暂无分享,去创建一个
Calcific uraemic arteriolopathy (CUA) or calciphylaxis affects 1–4% of the population with end stage renal disease (ESRD) and associated with high mortality. Most lesions (90%) occur on the lower extremities1 followed by the lower abdomen. We report a severe case of CUA in an uncommon location—the breasts.
A 54-year-old Caucasian woman with end stage kidney disease secondary to diabetic nephropathy, on maintenance haemodialysis for a year, was admitted with painful, open wound of the right breast. The initial lesion was …
[1] P. Parfrey,et al. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[2] Elie J. El-Charabaty,et al. Warfarin-induced calciphylaxis: a case report and review of literature , 2013, International Journal of General Medicine.
[3] S. Brunelli,et al. Sodium thiosulfate therapy for calcific uremic arteriolopathy. , 2013, Clinical journal of the American Society of Nephrology : CJASN.